Prostate Cancer
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE Study.
November 9, 2023
AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer
November 8, 2023
Association of Frailty and Complications Following Prostate Biopsy: Results from a Population-Based, Privately Insured Cohort.
November 8, 2023
Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer.
November 8, 2023
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer.
November 8, 2023
Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer.
November 8, 2023
Comparison of salvage radical prostatectomy vs. salvage ablation therapy for biopsyproven radio-recurrent localized prostate cancer.
November 8, 2023
A conserved mechanism for JNK-mediated loss of Notch function in advanced prostate cancer.
November 8, 2023
Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?
November 7, 2023
Effect of omega-3 fatty acid diet on prostate cancer progression and cholesterol efflux in tumor-associated macrophages-dependence on GPR120.
November 7, 2023